Clovis Oncology Inc. (CLVS) surged 5.7% or 3.23 to $59.99. It is around 733871 shares traded, which is 58.7% compare to the average total volume 1.25 million. The market cap of CLVS is $3.02 billion. The year to date change is -14.07%. The 52 week price range is from $45.42 to $99.45. Price of CLVS have changed -3.81% during last week. It have changed -13.87% over last month, -24.89% over last 3 months, -34.79% over last 6 months and -3.52% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CLVS is 63.25. It is 5.43% above current price. The 200-day Moving Averages for CLVS is 69.46. It is 15.79% above current price. The 52-week High is 99.45. It is 65.78% from the current price. The 52-week Low is 45.42. It is -24.29% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of CLVS is 6.09 on 2017-12-29. Short % to float is 14.35%. There are some statistics of CLVS. It is has market cap $3.02 billion. The share outstanding is 50.35 million. The average volume is 1.25 million. The revenue is 38.55M. The gross profit is 30.44M. The percent of top 15 Institution holding is 96.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CLVS is -203.61%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CLVS is -59.79%.